Effectiveness and Safety in Administrating CNU® Capsule to Refractory Functional Dyspepsia Patients
Status:
Recruiting
Trial end date:
2021-12-30
Target enrollment:
Participant gender:
Summary
Refractory Functional Dyspepsia (FD) means a state that no symptom was improved in spite of
appropriate treatment for the FD.
It may be challenging to discriminate the symptoms of FD from the symptoms of bile dyspepsia
resulting from the biliary system. As the bile dyspepsia may induce epigastralgia as with
functional dyspepsia and both imaging medical tests and blood tests show normal findings, it
is difficult to discriminate it from the FD with only these tests.
Thus this study intends to perform a therapeutic use clinical study for efficacy and safety
on symptom improvement by administrating CNU capsule to the patients with RFD.